PsyBio Therapeutics to Seek Approval of Proposed Share Consolidation at Annual and Special Meeting of Shareholders Post published:June 29, 2022 Post category:Press Release
Psychedelic Bulletin #108 – COMPASS Survives Patent Challenges; MindMed Secures Candyflipping IP; Will Psychedelics Companies Protect Access to Abortion for Employees? Post published:June 27, 2022 Post category:Psychedelic Bulletin
Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization Post published:June 27, 2022 Post category:Press Release
Incannex to Present at the H.C. Wainwright First Annual Mental Health Conference Post published:June 27, 2022 Post category:Press Release
Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond Post published:June 24, 2022 Post category:Press Release
Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022 Post published:June 23, 2022 Post category:Press Release
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference Post published:June 23, 2022 Post category:Press Release
Silo Pharma Expands License Agreement and Patent Portfolio Post published:June 23, 2022 Post category:Press Release
Numinus Applies for International Patent Filing of Psychedelics Production Process Post published:June 22, 2022 Post category:Press Release